Drugs / Mebendazole
last change 25 days ago re-read 9 days ago

Mebendazole

Small molecule

Developed for
hookworm infectious disease · anaplastic astrocytoma · anemia · helminthiasis · necatoriasis · trichuriasis · amebiasis · anaplastic oligodendroglioma
+19 more · ancylostomiasis · ascariasis · brainstem cancer · cancer · colorectal cancer · deficiency anemia · diffuse intrinsic pontine glioma · glioblastoma · gliosarcoma · hepatocellular carcinoma · high grade astrocytic tumor · medulloblastoma · neoplasm · optic nerve glioma · parasitic intestinal disorder · pilomyxoid astrocytoma · pleomorphic xanthoastrocytoma · parasitic infectious disease · ulcerative colitis
Investigated by
Johns Hopkins Bloomberg School of Public Health · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Swiss Tropical & Public Health Institute · UNICEF · University Ghent · World Health Organization
+44 more · Accelerate Brain Cancer Cure · Aga Khan University · Asociacion Civil Selva Amazonica · Bill and Melinda Gates Foundation · Boston Children's Hospital · Canadian Institutes of Health Research (CIHR) · Centre de Recherche Médicale de Lambaréné · Commonwealth Scientific and Industrial Research Organisation, Australia · Cornell University · Dr. Frank Arguello Cancer Clinic · Fundación Huésped · Ghana Health Services · Health Clinics Limited · HopeXchange Medical Center, Ghana · Institut Pasteur · Institut Pasteur, Cambodia · Institute of Liver and Biliary Sciences, India · Instituto de Ciencia y Medicina Genomica, Torreon, Coah. Mexico www.institutodeciencia.com · Ivo de Carneri, Pemba Island, Tanzania · Janssen Pharmaceuticals · Janssen Research & Development, LLC · Janssen-Cilag Ltd. · Jimma University · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Julie Krystal · Kintampo Health Research Centre, Ghana · Liberia Institute of Statistics and Geo-Information Services · McGill University · McGill University Health Centre/Research Institute of the McGill University Health Centre · Ministry of Health, Liberia · National Institute of Malariology, Parasitology and Entomology, Vietnam · Noguchi Memorial Institute for Medical Research · Oswaldo Cruz Foundation · PATH · Public Health Laboratory Ivo de Carneri · Queensland Institute of Medical Research · Tanta University · The University of Queensland · Thrasher Research Fund · University of Kelaniya · University of Nottingham · University of Yaounde 1 · VLIR-UOS Institutional University Cooperation · Yale University

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) VERMOX — 1974-06-28 fda.gov ↗

Trials 21

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT02644291 May 2016 → Jun 2022 anaplastic astrocytoma, anaplastic oligodendroglioma, brainstem cancer, glioblastoma +1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Completed No outcome recorded
Phase 1 NCT02051738 Feb → Apr 2014 — Janssen Research & Development, LLC Completed No outcome recorded
Phase 1 NCT01729260 Apr 2013 → Sep 2016 high grade astrocytic tumor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT01837862 Oct 2013 → Apr 2024 anaplastic astrocytoma, diffuse intrinsic pontine glioma, gliosarcoma, optic nerve glioma +2 Julie Krystal Completed No outcome recorded
Phase 22 trials · 1 missed
Phase 2 NCT03995680 Jul → Oct 2019 hookworm infectious disease Swiss Tropical & Public Health Institute Completed Missed primary
Phase 2 NCT02366884 Jul 2011 → Dec 2022 neoplasm Dr. Frank Arguello Cancer Clinic Unknown No outcome recorded
Phase 36 trials · 1 missed
Phase 3 NCT02201381 May 2022 → May 2027 cancer Health Clinics Limited Withdrawn No outcome recorded Stop: Enrollment
Phase 3 NCT03925662 Apr 2019 → Dec 2028 expected colorectal cancer Tanta University Recruiting No outcome recorded
Phase 3 NCT01350271 May → Jun 2011 necatoriasis University of Kelaniya Completed No outcome recorded
Phase 3 NCT01173562 Feb → Mar 2010 — Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Completed No outcome recorded
Phase 3 NCT00116493 Apr 2004 → May 2007 anemia Johns Hopkins Bloomberg School of Public Health Completed Missed primary
Phase 3 NCT00148629 Apr 2004 → Jan 2008 anemia, fetal growth restriction Cornell University Completed No outcome recorded
Phase 47 trials · 1 met primary · 1 missed
Phase 4 NCT04326868 Nov 2019 → Dec 2020 helminthiasis Centre de Recherche Médicale de Lambaréné Completed No outcome recorded
Phase 4 NCT03278431 Sep → Nov 2017 hookworm infectious disease Swiss Tropical & Public Health Institute Completed Met primary
Phase 4 NCT03261596 Sep → Dec 2017 hookworm infectious disease PATH Withdrawn No outcome recorded
Phase 4 NCT01379326 Dec 2011 → Dec 2012 ancylostomiasis, ascariasis, necatoriasis, trichuriasis University Ghent Completed No outcome recorded
Phase 4 NCT01314937 Sep 2011 → Jul 2013 nutritional deficiency disease, parasitic intestinal disorder McGill University Health Centre/Research Institute of the McGill University Health Centre Completed Missed primary
Phase 4 NCT01327469 Dec 2010 → Feb 2011 trichuriasis University Ghent Completed No outcome recorded
Phase 4 NCT02385058 Oct 2005 → Jan 2006 amebiasis, helminthiasis Janssen-Cilag Ltd. Completed No outcome recorded
Phase not applicable2 trials
— NCT05073562 Oct → Dec 2021 deficiency anemia, folic acid deficiency anemia, iron deficiency anemia Boston Children's Hospital Withdrawn No outcome recorded Stop: Business
— NCT04443049 Jul 2020 → Jun 2022 cirrhosis of liver, hepatocellular carcinoma Institute of Liver and Biliary Sciences, India Unknown No outcome recorded
Comparator or background therapy10 trials
Phase 2 NCT06720259 Comparator Apr → May 2025 ascariasis, hookworm infectious disease, trichuriasis Jennifer Keiser Completed No outcome recorded
Phase 2 NCT03757403 Background May → Nov 2020 — RDD Pharma Ltd Withdrawn No outcome recorded
Phase 3 NCT06800248 Comparator Sep 2026 → Apr 2027 expected ascariasis, hookworm infectious disease, trichuriasis Swiss Tropical & Public Health Institute Not yet recruiting No outcome recorded
Phase 3 NCT06736691 Comparator Nov 2025 → Jul 2026 ascariasis, hookworm infectious disease, trichuriasis Swiss Tropical & Public Health Institute Completed No outcome recorded
Phase 3 NCT02034162 Comparator Dec 2014 → Sep 2015 helminthiasis Janssen Research & Development, LLC Completed No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2019-04-09 Janssen Research & Development, LLC Regulatory New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification jnj.com ↗
Raritan, N.J., April 9, 2019 – Janssen Pharmaceutica N.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that the World Health Organization (WHO) has prequalified the company’s new pediatric formulation of a treatment for intestinal worms.

Evidence & citations 19 cited values

Every value below carries the sentence it was read from. 35 sources stand behind the page.

FieldValueCited text
Known as mebendazole “Participants were randomly assigned to one of three treatment arms. On the first and third days, all participants got albendazole 400 mg, and on the second day, albendazole...” PMID 38563751 ↗ Apr 2024
30

“Nitazoxanide, Chloroquine, Albendazole, Ivermectin, Mebendazole, Metronidazole, Praziquantel, Levamisole” NCT02366884 ↗

“Albendazole treatment, 400 mg x 2/d (or mebendazole if adverse effects)” NCT02876146 ↗

“Oral Mebendazole 100mg uid, for study duration.” NCT02201381 ↗

NCT00116493 ↗

NCT01350271 ↗

NCT05073562 ↗

NCT06736691 ↗

NCT03278431 ↗

NCT06335160 ↗

NCT01173562 ↗

Show 20 more sources

Known as Emverm ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as MBD “This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB...” NCT01050452 ↗
Known as MBZ “Purpose: To assess the efficacy of three proposed anthelminthic combination regimens for the treatment of strongyloidiasis using real-time polymerase chain reaction (real-time...” PMID 41364144 ↗ Dec 2025
2

“A randomised clinical trial was conducted in Kabale District, southwestern Uganda, to compare the efficacies of single and double doses of a combination of 400mg albendazole...” PMID 21885077 ↗ Aug 2011

“The primary objective is: (1) to monitor the efficacy a single dose 500 mg of mebendazole (MBZ) against Soil-Transmitted Helminths (STH) infections by means of Faecal Egg...” NCT01379326 ↗

Known as Mebendazol ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Mebendazole polymorph c ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Mebendazolum ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Mebenvet ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as NSC-184849 ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Ovitelmin ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Pantelmin ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as R 17,635 ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Telmintic ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Vermicidin ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Vermox ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Known as Zhihuanqing ChEMBL registry synonym — accepted as the source's own label CHEMBL685 ↗
Action Inhibit “Mebendazole has broad range of action by not only inhibiting angiogenesis and pro-survival pathways of MAPK” NCT04443049 ↗
Modality Small molecule “A Randomized Controlled Clinical Trial (RCT) cohort study, to evaluate the efficacy and safety of three benzimidazole derivates drug (Albendazole, Mebendazole, Albendazole...” NCT04326868 ↗
Route Oral “route= oral use.” NCT01173562 ↗